HONG KONG, Mar 23, 2026 - (ACN Newswire) – Everest Medicines today announced that it has entered into an Asset Purchase Agreement with Corxel Pharmaceuticals Hong Kong Limited. Under the agreement, ...

On Wednesday, March 25, members and guests of the Pattaya City Expats Club were treated to a practical, case-driven lesson in ...

RESET-PSVT is intended to generate prospective evidence to inform the real-world use of recently approved CARDAMYST and demonstrate its potential impact on the acute management of PSVT. Results are ...

Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Express ...

Cryopreserver Vitrafy has reported promising initial results from a follow-up blood platelet freezing trial with the US ...

Heart failure is common in people who have atrial fibrillation detected during screening, according to a presentation today ...

A prespecified analysis of the NOAH-AFNET 6 trial investigated the impact of kidney function on cardiovascular outcome in ...

Tafamidis treatment was associated with a significant reduction in the risk of ischemic stroke in patients with ATTR-CM and AF.

Frequently a precursor to stroke or heart failure, a heart condition known as atrial fibrillation, goes undetected until it has progressed to an advanced stage. But atrial fibrillation, which is ...

The US Army's Bavaria base hosts over 16,000 troops ready for instant deployment. Its origins date back to pre-World War I. Later, it became a major training hub for the German Wehrmacht. Today, US ...

BACKGROUND: With the increasing diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) at earlier stages and new ...

The first RCT of microaxial flow pump support in high-risk PCI shows no benefit for Impella and some harm. John Mandrola, MD, asks why the device was approved for this use before supporting evidence.